Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 14458 clinical trials
featured
Calling all young people with ASTHMA!

Everyone's asthma is different, so new treatments are always needed. Doctors need people like you to join a new research study, to test a new investigational treatment. Can you help us?

  • 1050 views
  • 23 Nov, 2020
  • 1 location
featured
Obsessive-Compulsive Disorder

Care medications. Eligibility Criteria: It is required that all women of child-bearing potential (WOCBP) who are sexually active agree to use two methods of contraception for the

  • 3816 views
  • 07 Nov, 2020
  • 1 location
featured
Study in Parkinson Disease of Exercise

This study is a Phase 3 multi-site, randomized, evaluator-masked, study of endurance treadmill exercise on changes in the Movement Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS) Part III score at 12 months among persons with early stage Parkinson disease. 370 participants will be randomly assigned to 2 groups: 1)60-65% HRmax …

  • 0 views
  • 30 Apr, 2021
  • 6 locations
featured
Sternal Cerclage (sternal bone closure after open heart surgery)

The purpose of the study is to learn which treatment option is better for patients who have multi-vessel coronary artery disease (blockages in more than one vessel supplying blood to the heart muscle).

coronary revascularization
revascularisation
acute coronary syndrome
  • 1160 views
  • 05 Feb, 2021
  • 1 location
featured
PRB244-01: Treatment of Pruritus in Adults With a History of Atopic Dermatitis  

This is a double-blind, randomized, vehicle-controlled study to assess the efficacy, safety, and tolerability of 2 doses of B244 for the treatment of pruritus in adults with a history of atopic dermatitis. Subjects who meet the study entry criteria will be randomized in a 1:1:1 ratio to receive twice daily …

  • 0 views
  • 29 Apr, 2021
  • 1 location
featured
A Phase 2, Open-Label, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement

This is an open-label, monotherapy study of INCB054828 in subjects with myeloid/lymphoid neoplasms with FGFR1 rearrangement.  Subjects will receive a once daily (QD) dose of INCB054828 at 13.5 mg on a 2-week-on–therapy and 1-week-off–therapy schedule.  With Protocol Amendment 3, the administration schedule will be adjusted, and newly enrolled subjects will …

myeloid neoplasm
FGFR1
lymphoid malignancy
  • 79 views
  • 14 Dec, 2020
  • 35 locations
featured
COVID-19 Treatment Trial: Investigational Medication as a Non-antiviral Immunomodulator

Day 1 of the study. Total of 230 subjects will be enrolled; half will receive CD24Fc and half will receive placebo. All subjects will be treated with the best available treatment. The follow up period

  • 3989 views
  • 17 Jun, 2020
  • 4 locations
featured
Cognitive Fitness for Depression in Older Adults

This research is being done to determine if computerized administered cognitive fitness activities will improve thinking and depression in older depressed adults who are being treated with antidepressants. The investigators are also interested in whether participating in the treatment will result in changes to brain activity measured with magnetic resonance …

  • 0 views
  • 23 Mar, 2021
  • 1 location
featured
Study to Evaluate the Safety Tolerability and Efficacy of BGE-175 in Participants 60 Years of Age and Hospitalized With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure

The primary objectives of this study are to evaluate the safety, tolerability, and efficacy of BGE-175 in participants 60 years of age hospitalized with documented COVID-19.

  • 0 views
  • 29 Mar, 2021
featured
Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies

The study will determine Recommended Phase 2 Dose for all study drugs, based on the safety and tolerability of the following combinations: INCAGN02385 + INCAGN02390 and INCAGN02385 + INCAGN02390

  • 0 views
  • 04 Aug, 2020
  • 3 locations